Orum Therapeutics Holds Extraordinary Shareholders Meeting
Bitget2026/10/23 08:05- Orum Therapeutics shareholders approved amendments to the articles of incorporation at an extraordinary general meeting on Oct. 23, 2026.
- Shareholders approved appointments of Geoffrey Harris Meyerson as non-executive director and Peter Unnam Park as independent director.
- Separate resolutions to grant stock options and approve stock option grants also passed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street veteran Yardeni: Cooling inflation is expected, 5% US Treasury bonds are "very attractive"
Ed Yardeni, President of Yardeni Research, stated that with inflation expected to cool down, the yield on the 10-year US Treasury at around 5% looks "very attractive."
Euro: Positive outlook hinges on 1.1280 against US Dollar - UOB
USD/JPY Price Forecast: Remains close to 20-day EMA
OpenAI president confirms IPO in 2027: enterprise clients have become the main source of revenue, but funding target has shrunk from 30 billions to 20 billions
OpenAI President Brockman stated that enterprise sales have contributed the majority of the company's revenue, and the company will be ready for an IPO by 2027. OpenAI is accelerating fundraising and competing with Anthropic, which is aiming to go public by the end of the year.
Crypto prices
More
